In the in vitro cell experiments, Aβ42-damaged SH-SY5Y cells were used to construct an in vitro model of AD, which corresponded to the APP/PS1 double transgenic mouse model used in the animal experiments. This evidence concerns the gene APP and Alzheimer disease.